European Journal of Medicinal Chemistry p. 321 - 326 (1995)
Update date:2022-09-26
Topics:
Komiotis, D.
Pananookooln, S.
Zaw, K.
Dieter, J. P.
Breton, G. C. Le
Venton, D. L.
The title compounds have been synthesized and their in vitro thromboxane A2(TxA2) receptor antagonist activity evaluated.Both cis and trans isomers (1,2) were shown to specifically inhibit submaximal human platelet aggregation induced by 225 nM U46619 in a dose-dependent manner with an IC50 of 1 μM.The concentration of 1 and 2 required to completely block maximal aggregation induced by 3 μM U46619 was 3 μM. thromboxane A2/ receptor antagonist/ platelet aggregation/ 1,3-dioxolane
View MoreHangzhou Pharma & Chem Co.,Ltd.
Contact:+86-571-87040515
Address:No,139Qingchun Rd
YingYing Pharmaceutical Co.,Ltd
Contact:86-18854126208
Address:55#, yingxiongshan road
ChangZhou XiaQing Chemical Co., Ltd.
Contact:+86-519-88721665
Address:3# Hengluo Road, Henglin Town, Changzhou City, Jiangsu Province,China
Airsea(Taizhou) Pharmaceutical Limited(expird)
Contact:+86-576-88057622
Address:Dubei, Duqiao, Linhai, Taizhou, Zhejiang, China Zip: 317016
Contact:+86 512 6287 2180
Address:398 Ruoshui Road, Suzhou Industrial Park, Suzhou, Jiangsu, P. R. China
Doi:10.1016/S0040-4039(00)85246-6
(1986)Doi:10.1039/c39900000897
(1990)Doi:10.1039/c2ob06934b
(2012)Doi:10.1007/BF00487436
(1990)Doi:10.1021/ol2011067
(2011)Doi:10.1016/0022-328X(86)82021-6
(1986)